Our business development director, Jan Van Hauwermeiren, will represent RheaVita at CPHI taking place November 1-3 2022 in Frankfurt.

We attended the BIOPROCESS INTERNATIONAL and CELL & GENE THERAPY MANUFACTURING & COMMERCIALIZATION conference in Boston

We attended the 2022 PDA BioManufacturing Conference taking place from September 20 until 21 in Amsterdam.

On September 15 our CEO Thomas De Beer presented our technology during the 2022 CESPE conference.

From Monday August 21 until Friday August 26 we will participate in the Achema Exhibition taking place in Frankfurt.

Belgian Economic Mission to the USA